Evaluation of chronic urticaria in patients with hashimoto thyroiditis

Citation
Aa. Kandeel et al., Evaluation of chronic urticaria in patients with hashimoto thyroiditis, J CLIN IMM, 21(5), 2001, pp. 335-347
Citations number
39
Categorie Soggetti
Immunology
Journal title
JOURNAL OF CLINICAL IMMUNOLOGY
ISSN journal
02719142 → ACNP
Volume
21
Issue
5
Year of publication
2001
Pages
335 - 347
Database
ISI
SICI code
0271-9142(200109)21:5<335:EOCUIP>2.0.ZU;2-Z
Abstract
The coincidence of Hashimoto thyroiditis (HT) and chronic idiopathic urtica ria (CIU) is a commonly observed phenomenon in western New York. Previous l iterature suggested that there may be a direct relationship between them. W e undertook these studies to determine whether humoral or cell-mediated mec hanisms might link HT and CIU. Skin biopsies from patients with CIU, with or without HT, were indistinguis hable by light microscopy. No immune complex deposition was observed, altho ugh only the skin from patients with CIU and HT contained perivascular fibr in deposits. Similarly, inummohistochemical studies evaluating cellular exp ression of CD3, CD4, CD8, CD20, and CD68 failed to differentiate between CI U with or without HT. Analysis of VG restriction in thyroid tissue of patie nts with HT and the skin of patients with CIU and HT by in situ polymerase chain reaction failed to reveal any oligoclonal T-lymphocyte subpopulations . In contrast, only patients with CIU and HT had anti-Fc epsilon RI antibod ies in their sera that could induce degranulation of normal basophils. Some sera from patients with CIU and HT caused degranulation of normal basophil s in the absence of anti-FceRI. The factor causing basophil degranulation i n these sera was not determined. Patients with CIU and HT failed to improve clinically with thyroid replacement therapy. All CIU patients were equally well managed with symptomatic therapies. In conclusion, HT likely represents a marker of other autoimmunity, rather than being a direct causative agent in CIU. Management of CIU, with or with out HT and with or without anti-FceRI antibodies, should be the same. Futur e studies will have to examine whether cell-mediated responses participate in CIU, especially in association with HT.